|
Index of reports
> Death (76)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Reyataz (Atazanavir) death. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 76 Next >>
Possible Reyataz side effects in male
Reported by a physician from France on 2012-08-21
Patient: male
Reactions: Dysmorphism, Foetal Exposure During Pregnancy, Renal Dysplasia, Intestinal Malrotation, Persistent Cloaca, Trisomy 21, Bladder Dilatation, Cleft Palate, Protrusion Tongue, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-20
Patient: male
Reactions: Bladder Dilatation, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in female
Reported by a physician from France on 2012-08-17
Patient: female
Reactions: Foetal Exposure During Pregnancy, Congenital Central Nervous System Anomaly, Abortion Induced, Congenital Absence of Cranial Vault
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Cytogenetic Abnormality, Brain Malformation, Spina Bifida, Abortion Induced, Vertical Talus
Adverse event resulted in: death
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Isentress
Indication: Maternal Exposure Timing Unspecified
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient:
Reactions: Foetal Exposure During Pregnancy, Congenital Anomaly, Abortion Spontaneous
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a consumer/non-health professional from France on 2012-08-16
Patient: male
Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Dosage: 1 film coated tablet daily
Start date: 2012-01-24
Reyataz
Start date: 2012-01-24
Truvada
Start date: 2011-01-24
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-16
Patient: male
Reactions: Bladder Dilatation, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Cytogenetic Abnormality, Premature Baby, Foetal Exposure During Pregnancy, Hypoxia, Limb Malformation, Cerebral Haemorrhage, Genetic Polymorphism
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-14
Patient:
Reactions: Hypoplastic Left Heart Syndrome, Foetal Exposure During Pregnancy, Stillbirth, Heart Disease Congenital
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Truvada
Indication: Product Used FOR Unknown Indication
Possible Reyataz side effects in 57 year old female
Reported by a physician from United States on 2012-08-10
Patient: 57 year old female
Reactions: Chronic Obstructive Pulmonary Disease, Myocardial Infarction, Arrhythmia
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in male
Reported by a physician from France on 2012-08-06
Patient: male
Reactions: Bladder Dilatation, Dysmorphism, Renal Aplasia, Anal Atresia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Dosage: 1 film coated tablet daily
Start date: 2012-01-24
Reyataz
Start date: 2012-01-24
Truvada
Start date: 2011-01-24
Possible Reyataz side effects in male
Reported by a physician from France on 2012-07-30
Patient: male
Reactions: Foetal Exposure During Pregnancy, Intestinal Malrotation, Renal Dysplasia, Persistent Cloaca, Trisomy 21, Cleft Palate, Bladder Dilatation, Protrusion Tongue, Amniotic Fluid Volume Decreased, Renal Aplasia, LOW SET Ears, Abdominal Distension, Anal Atresia, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Start date: 2012-01-24
Truvada
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-07-30
Patient: male
Reactions: Dysmorphism, Bladder Dilatation, Rectal Perforation, Amniotic Fluid Volume Decreased, Renal Aplasia, Intestinal Malrotation, Persistent Cloaca, Eagle Barrett Syndrome
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Dosage: unk
Indication: HIV Infection
Start date: 2012-01-01
Reyataz
Dosage: unk
Indication: HIV Infection
Start date: 2012-01-01
Truvada
Dosage: unk
Indication: HIV Infection
Start date: 2012-01-01
Possible Reyataz side effects in 27 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-26
Patient: 27 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: HIV Infection
Reyataz
Indication: Acquired Immunodeficiency Syndrome
Possible Reyataz side effects in 81 year old female
Reported by a consumer/non-health professional from United States on 2012-07-17
Patient: 81 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 57 year old female
Reported by a consumer/non-health professional from United States on 2012-07-09
Patient: 57 year old female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 41 year old female
Reported by a physician from Canada on 2012-06-29
Patient: 41 year old female
Reactions: Breast Cancer, Back Pain, Weight Increased, Breast Cancer Metastatic, Hydrocephalus, Metastases To Bone
Adverse event resulted in: death, hospitalization, disablity
Drug(s) suspected as cause:
Lamivudine
Indication: HIV Infection
Start date: 2006-05-12
Norvir
Indication: HIV Infection
Start date: 2006-03-12
Reyataz
Indication: HIV Infection
Start date: 2006-05-12
Study Drug MK-0518 (Non-Abbott)
Dosage: blinded treatment
Administration route: Oral
Indication: HIV Infection
Start date: 2006-05-12
End date: 2009-05-13
Study Drug MK-0518 (Non-Abbott)
Administration route: Oral
Start date: 2009-03-14
End date: 2010-07-07
Viread
Indication: HIV Infection
Start date: 2006-05-12
Other drugs received by patient: Robaxin; Oxycodone HCL; Ibuprofen (Advil); Acetaminophen; Palafer; Acetaminophen; Zomig; Dilaudid
Possible Reyataz side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-24
Patient: female
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 56 year old male
Reported by a consumer/non-health professional from United States on 2012-06-22
Patient: 56 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 27 year old male
Reported by a consumer/non-health professional from United States on 2012-06-15
Patient: 27 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Indication: Acquired Immunodeficiency Syndrome
Reyataz
Indication: HIV Infection
Possible Reyataz side effects in 23 year old male
Reported by a pharmacist from United States on 2012-06-11
Patient: 23 year old male
Reactions: Hepatitis
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 57 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-29
Patient: 57 year old male
Reactions: Septic Shock
Adverse event resulted in: death
Drug(s) suspected as cause:
Abacavir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-20
Reyataz
Dosage: started art in 2000
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-20
Ritonavir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-20
Zidovudine
Administration route: Oral
Indication: HIV Infection
Start date: 2005-11-20
Other drugs received by patient: Minoxidil; Lovastatin; Clonidine; Phoslo; Lantus; Hydralazine HCL
Possible Reyataz side effects in 50 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-25
Patient: 50 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in female
Reported by a consumer/non-health professional from France on 2012-05-23
Patient: female
Reactions: Congenital Central Nervous System Anomaly
Adverse event resulted in: death
Drug(s) suspected as cause:
Norvir
Start date: 2005-10-01
Reyataz
Start date: 2005-01-01
Truvada
Start date: 2005-10-01
Possible Reyataz side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-23
Patient: 31 year old male
Reactions: Death
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 57 year old male
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: 57 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-12
Patient:
Reactions: Trisomy 21, Abortion, Foetal Exposure During Pregnancy
Adverse event resulted in: death
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Isentress
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Tenofovir Disoproxil Fumarate
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-04-05
Patient:
Reactions: Trisomy 21, Foetal Exposure During Pregnancy, Abortion
Adverse event resulted in: death
Drug(s) suspected as cause:
Combivir
Indication: Maternal Exposure Timing Unspecified
Isentress
Indication: Maternal Exposure Timing Unspecified
Kaletra
Indication: Maternal Exposure Timing Unspecified
Reyataz
Indication: Maternal Exposure Timing Unspecified
Tenofovir Disoproxil Fumarate
Indication: Maternal Exposure Timing Unspecified
Possible Reyataz side effects in 57 year old male
Reported by a consumer/non-health professional from United States on 2012-04-03
Patient: 57 year old male
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Reyataz
Possible Reyataz side effects in 66 year old male
Reported by a physician from Japan on 2012-03-15
Patient: 66 year old male
Reactions: Blood Alkaline Phosphatase Increased, Gastrointestinal Haemorrhage, Aspartate Aminotransferase Increased, Alanine Aminotransferase Increased
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Epzicom
Dosage: 1 df = 1 tabs
Administration route: Oral
Indication: HIV Infection
Start date: 2010-04-03
End date: 2010-04-20
Reyataz
Administration route: Oral
Indication: HIV Infection
Start date: 2010-04-03
End date: 2010-04-20
Zithromax
Indication: Prophylaxis
Start date: 2010-04-03
End date: 2010-04-17
Page 1 Next >>
|
